PrEP

Two Black hands with one holding a blue pill

ICYMI: FDA Approves HIV Prevention Drug That Isn't Safety Tested for All

The Food and Drug Administration says that safety trials for Descovy primarily tested White cisgender men.

AIDS quilt on the National Mall in Washington, D.C.

ICYMI: HIV Prevention Drug PrEP to Be Covered by Most Insurance Plans

At $2,000 per month, the pill is currently inaccessible to most of the people who are at highest risk of contracting HIV.

A pair of blue-gloved hands gives a white stick to a pair of Black hands. Light blue paper lines the table below, a blue and white box of gloves sits on the table

The Best Medication to Prevent HIV is Hard to Find Where It's Needed Most

The dangerously scarce availability of PrEP is contributing to high HIV infection rates in Black men.